ZERIA PHARMACEUTICAL CO.,LTD. 4559Short Interest
No institution currently reports a short position of 0.5% or more in ZERIA PHARMACEUTICAL CO.,LTD. (4559). The last disclosure was on 2025-09-29 (Nomura International plc, 0.49%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
18 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 4 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2019-08-05 |
|---|---|
| Latest disclosure | 2025-09-29 (Nomura International plc, 0.49%) |
| Reporting institutions | 4 firms (18 reports) |
| Peak estimated short interest | 0.71% (2021-04-13, 1 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 3 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- スパークス・アセット・マネジメント株式会社
- Nomura International plc
- Integrated Core Strategies (Asia) Pte. Ltd.
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2019-10-08 | Morgan Stanley MUFG Securities Co., Ltd. | Position 262,124 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2025-09-29 | Nomura International plc | Position 258,640 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2022-09-29 | スパークス・アセット・マネジメント株式会社 | Position 257,900 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2022-10-28 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 13,600 shares | Ratio 0.02% | ▼0.48% | Below 0.5% |
Disclosure History 18 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2025-09-29 | Nomura International plc | Position 258,640 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2025-08-06 | Nomura International plc | Position 275,930 shares | Ratio 0.51% | ▲0.11% | — |
| 2025-06-20 | Nomura International plc | Position 197,597 shares | Ratio 0.37% | ▼0.13% | Below 0.5% |
| 2025-06-17 | Nomura International plc | Position 266,474 shares | Ratio 0.50% | ▲0.09% | — |
| 2022-10-28 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 13,600 shares | Ratio 0.02% | ▼0.48% | Below 0.5% |
| 2022-10-26 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 269,516 shares | Ratio 0.50% | ▲0.10% | — |
| 2022-09-29 | スパークス・アセット・マネジメント株式会社 | Position 257,900 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2022-08-04 | スパークス・アセット・マネジメント株式会社 | Position 318,700 shares | Ratio 0.59% | ▼0.10% | — |
| 2022-07-01 | スパークス・アセット・マネジメント株式会社 | Position 367,800 shares | Ratio 0.69% | ▼0.02% | — |
| 2021-04-13 | スパークス・アセット・マネジメント株式会社 | Position 380,400 shares | Ratio 0.71% | ▲0.11% | — |
| 2021-03-18 | スパークス・アセット・マネジメント株式会社 | Position 323,000 shares | Ratio 0.60% | ▲0.10% | — |
| 2020-09-28 | スパークス・アセット・マネジメント株式会社 | Position 268,400 shares | Ratio 0.50% | ▲0.07% | — |
| 2019-10-08 | Morgan Stanley MUFG Securities Co., Ltd. | Position 262,124 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2019-09-18 | Morgan Stanley MUFG Securities Co., Ltd. | Position 268,924 shares | Ratio 0.50% | ▲0.01% | — |
| 2019-09-12 | Morgan Stanley MUFG Securities Co., Ltd. | Position 263,424 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2019-08-22 | Morgan Stanley MUFG Securities Co., Ltd. | Position 309,924 shares | Ratio 0.58% | ▼0.02% | — |
| 2019-08-08 | Morgan Stanley MUFG Securities Co., Ltd. | Position 320,424 shares | Ratio 0.60% | ▲0.08% | — |
| 2019-08-05 | Morgan Stanley MUFG Securities Co., Ltd. | Position 279,324 shares | Ratio 0.52% | ▲0.10% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| EIKEN CHEMICAL CO.,LTD.4549 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| JCR Pharmaceuticals Co.,Ltd.4552 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| TOWA PHARMACEUTICAL CO.,LTD.4553 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| Fuji Pharma Co.,Ltd.4554 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| CHUKYO IYAKUHIN CO.,LTD.4558 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| AnGes,Inc.4563 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| OncoTherapy Science,Inc.4564 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Nxera Pharma Co.,Ltd.4565 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| DAIICHI SANKYO COMPANY,LIMITED4568 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| KYORIN Pharmaceutical Co.,Ltd.4569 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |